Ligand Pharmaceuticals Inc.
$283.49
-$1.21 (-0.43%)
$280.49Day Range$285.64
Key Statistics
Market Cap
$5.68B
Shares Outstanding
19.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 25, 1994
Round Lot
100
Locale
US
Trading Data
Day Open
$285.63
Day High
$285.64
Day Low
$280.49
Volume
372.8K
VWAP
$283.37
Prev Close
$284.70
Transactions
--
Acc. Volume
--
About Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
PHARMACEUTICAL PREPARATIONSSIC 283447 employees3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA, 92121858-550-7500IPO Nov 25, 1994US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000886163
- Composite FIGI
- BBG000BKF014
- Share Class FIGI
- BBG001S8CH99
- Ticker Root
- LGND
- SIC Code
- 2834
About Ligand Pharmaceuticals Inc. (LGND) Stock
Ligand Pharmaceuticals Inc. (LGND) closed the 2026-09-18 session at $283.49, down 0.43% versus the previous close (-1.21). The stock opened at $285.63 and traded between $280.49 and $285.64 during that session. Session trading volume was 373K shares. The volume-weighted average price (VWAP) is $283.37.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Ligand Pharmaceuticals Inc. has a market capitalization of $5.68 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. LGND is listed on the XNAS exchange. The company employs approximately 47 people. Ligand Pharmaceuticals Inc. is headquartered in SAN DIEGO, CA. The recorded listing date is 1994-11-25.
On this page you can find market LGND stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.